Revive Therapeutics Archives | Follow The Money Investor Group

Revive Therapeutics Announces United States Patent Grant for Cannabinoid Delivery System

Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, is pleased to announce the grant of United States Patent No. 10,104,888, titled "Tannin-chitosan composites," by the United States Patent and Trademark Office.

Revive Therapeutics Announces Collaboration and Royalty Agreement With Richmond Cannabis Co.

April 11, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, has entered into a non-binding letter of intent (the “LOI”) with Richmond Cannabis Co.

Revive Therapeutics Announces Results for the Three and Six Months Ended December 31, 2018

Feb. 28, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE:31R) (‘Revive’ or the ‘Company’), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, today announced its results for the three and six months ended December 31, 2018.

Revive Closes Over 1.4 Million in Non-Brokered Private Placement

Feb. 11, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV) (OTCQB: RVVTF) is pleased to announce that it has completed the second tranche of the previously announced in the December 7, 2018, January 23, 2019 and February 4, 2019 news releases non-brokered private placement of units of the Company (“Units”), at a price of $0.10 per Unit (the “Offering”).

Tag Archives: Revive Therapeutics